a 2007

Polymorphism at position-308 of the TNF-alpha gene influences outcome of anti-TNF-alpha therapy in rheumatoid arthritis:preliminary results

NĚMEC, Petr, Monika PÁVKOVÁ GOLDBERGOVÁ, Karel CHROUST, Anna VAŠKŮ, Miroslav SOUČEK et. al.

Basic information

Original name

Polymorphism at position-308 of the TNF-alpha gene influences outcome of anti-TNF-alpha therapy in rheumatoid arthritis:preliminary results

Name in Czech

Polymorfismus v pozici -308 v genu pro TNF alfa ovlivňuje výsledek anti TNF alfa terapie u pacientů s revmatoidní artritidou: předběžné výsledky

Authors

NĚMEC, Petr (203 Czech Republic, guarantor), Monika PÁVKOVÁ GOLDBERGOVÁ (203 Czech Republic), Karel CHROUST (203 Czech Republic), Anna VAŠKŮ (203 Czech Republic) and Miroslav SOUČEK (203 Czech Republic)

Edition

2007

Other information

Language

English

Type of outcome

Konferenční abstrakt

Field of Study

30000 3. Medical and Health Sciences

Country of publisher

United Kingdom of Great Britain and Northern Ireland

Confidentiality degree

není předmětem státního či obchodního tajemství

RIV identification code

RIV/00216224:14110/07:00040010

Organization unit

Faculty of Medicine

Keywords in English

TNF; gene; rheumatoid; arthritis

Tags

arthritis, gene, rheumatoid, TNF

Tags

International impact, Reviewed
Změněno: 6/4/2010 11:14, prof. RNDr. Monika Pávková Goldbergová, Ph.D.

Abstract

ORIG CZ

V originále

Rheumatoid arthritis (RA) is a model of multigenic inflammatory disorder in which tumor necrosis factor-alpha (TNF-alpha) plays an important role. Genetic factors may be implicated in the susceptibility to disease initiation as well as in severity of disease course. Elevated levels of TNF-alpha in the plasma and synovial fluid from RA patients may be associated with polymorphisms in the promoter region of the TNF-alpha gene. The aim of this study was to elucidate putative association between the -308 G/A polymorphism in the promoter region of the TNF-alpha gene and susceptibility to onset and severity of RA. A total of 130 RA patients and a control group of 150 healthy subjects with similar age and sex distribution were available for the study. All patients fulfilled the American College of Rheumatology revised criteria for RA. RA patients had a disease duration of at least 2 years. Radiographs of both hands of all RA patients were scored with the Steinbrocker method. There were 15 patients of stage I (nonerosive form) of RA and 114 patients of stages II-IV (erosive form). To assess the RA patient's functional ability, the Health Assessment Questionnaire (HAQ) was used. The -308 G/A promoter polymorphism of the TNF-alpha gene was detected by polymerase chain reaction and restriction fragment length polymorphism analysis. No differences in genotype distribution and allelic frequences of -308 G/A TNF-alpha promoter polymorphism have been found between RA patients and the control group. Significant differences have been observed within the RA group divided according to the radiographic progression of disease based on the Steinbrocker radiographic score and functional ability (HAQ). These results suggest an association of the -308 G/A polymorphism of the TNF-alpha gene with the severity of RA.

In Czech

Polymorfismus v pozici -308 v genu pro TNF alfa ovlivňuje výsledek anti TNF alfa terapie u pacientů s revmatoidní artritidou: předběžné výsledky

Links

NR7812, research and development project
Name: Genetická variabilita pro- a proti-zánětlivých cytokinů v patogenezi revmatoidní artritidy
Investor: Ministry of Health of the CR
Displayed: 15/11/2024 04:58